Thermo Fisher Scientific to Acquire Affymetrix for $14.00/Share in Cash

Thermo Fisher Scientific Inc. TMO, the world leader in serving science, and Affymetrix Inc. AFFX, a leading provider of cellular and genetic analysis products, today announced that their boards of directors have unanimously approved Thermo Fisher's acquisition of Affymetrix for $14.00 per share in cash. The transaction represents a purchase price of approximately $1.3 billion. Affymetrix's technologies enable parallel and multiplex analysis of biological systems at the cellular, protein and genetic level, facilitating the transition of research tools into clinical and applied markets. The company's products are used by customers working in life sciences and translational research, molecular diagnostics, reproductive health and agricultural biotechnology. Based in Santa Clara, California, See full press release